The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

With a market cap of $64.8 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company providing a wide ...

In 2018, CVS acquired the insurer, Aetna, and in 2007, the company acquired pharmacy services provider Caremark Rx. Adding Signify Health to the mix presents an opportunity for CVS to drive ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

CVS Health amended a previous layoff announcement ... The House Committee on the Judiciary is investigating whether CVS Caremark is actively violating antitrust law, referencing a government ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

We recently published a list of 10 Hottest Large-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

CVS Health Corporation is a vertically integrated healthcare corporation in the United States. The company owns a leading ...